Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA)

Historical Holders from Q4 2023 to Q3 2025

Symbol
MURA
Type / Class
Equity / Ordinary shares, nominal value $0.01 per share
Shares outstanding
17,255,853
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,321,151
Holdings value
$11,013,094
% of all portfolios
0%
Number of holders
58
Number of buys
27
Number of sells
33
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACORN BIOVENTURES, L.P. 7.6% +22% $3,369,527 +$547,205 1,286,079 +19% Anders Hove 31 Dec 2024
FELDMAN STUART 4.4% $2,005,872 765,600 Stuart Feldman 16 Apr 2025
As of 30 Sep 2025 Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,321,151 shares of 17,255,853 outstanding shares and own 31% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) own 30% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
ORBIMED ADVISORS LLC 3.4% $1,218,816 588,800 0%
Newtyn Management, LLC 3% $1,082,442 522,919 -8.3%
OMERS ADMINISTRATION Corp 3% $1,057,770 511,000
VANGUARD GROUP INC 2.6% $941,254 454,712 -41%
Rangeley Capital, LLC 1.8% $631,350 305,000 +556%
BlackRock, Inc. 1.7% $595,290 287,580 +0.41%
RBF Capital, LLC 1.6% $587,698 283,912 0%
MILLENNIUM MANAGEMENT LLC 1.5% $535,068 258,487 -18%
CITADEL ADVISORS LLC 1.5% $534,577 258,250 +257%
DELTEC ASSET MANAGEMENT LLC 1% $370,648 179,057
GEODE CAPITAL MANAGEMENT, LLC 1% $362,580 175,111 +0.2%
TORNO CAPITAL, LLC 0.99% $351,900 170,000
Yakira Capital Management, Inc. 0.95% $339,385 163,954
FNY Investment Advisers, LLC 0.85% $304,000 147,076 +3941%
RENAISSANCE TECHNOLOGIES LLC 0.85% $302,220 146,000 +1137%
MORGAN STANLEY 0.59% $211,497 102,173 +395%
PRIMECAP MANAGEMENT CO/CA/ 0.54% $192,096 92,800 0%
SIMPLEX TRADING, LLC 0.52% $186,000 90,256 +43%
STATE STREET CORP 0.49% $175,687 84,873 0%
PenderFund Capital Management Ltd. 0.48% $171,396 82,800
BML Capital Management, LLC 0.33% $119,025 57,500
Virtu Financial LLC 0.32% $115,000 55,721
Shay Capital LLC 0.26% $93,332 45,088
JANE STREET GROUP, LLC 0.24% $84,061 40,609
DIMENSIONAL FUND ADVISORS LP 0.23% $82,432 39,822 -13%

Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 5,321,151 $11,013,094 -$7,685,237 $2.07 58
2025 Q2 8,232,985 $20,335,094 +$3,120,880 $2.47 61
2025 Q1 8,395,072 $10,577,119 -$2,681,464 $1.26 62
2024 Q4 9,375,536 $30,188,503 -$4,619,940 $3.22 71
2024 Q3 9,521,654 $29,799,342 -$4,112,563 $3.13 69
2024 Q2 10,897,746 $34,217,578 -$6,397,175 $3.14 79
2024 Q1 12,252,400 $59,913,404 -$6,550,206 $4.89 94
2023 Q4 13,356,680 $79,068,382 +$79,068,258 $5.92 119